Pharmacogenomics—the study of how an individual’s genetic makeup influences their response to medications—has become one of the most important pillars of modern personalized…
In the last decade, pharmacogenomics (PGx) has moved from a niche research domain into a central pillar of precision medicine. Sequencing is now…
For years, pharmacogenomics (PGx) was seen as a future promise, a fascinating science that could someday make drug therapy safer and more effective….
In May 2024, the U.S. Food and Drug Administration (FDA) published a final rule that would bring laboratory-developed tests (LDTs) explicitly under the…
When you talk to Dr. Gualberto Ruaño, you don’t just hear about science — you hear about purpose. A physician, geneticist, and entrepreneur,…
Grand View Research has just released its latest report on the pharmacogenomics technology market, offering fresh insights into one of the fastest-growing areas…
Pharmacogenetic testing has emerged as one of the most exciting frontiers in personalized medicine. By analyzing a patient’s genetic makeup, these tests promise…
The promise of precision medicine lies in its ability to tailor treatments to the genetic makeup of each patient. Pharmacogenomics is central to…
This blog provides a comprehensive overview of the FDA’s current and draft guidance on pharmacogenomic data submission, highlighting key regulatory requirements, submission algorithms, voluntary submissions, and practical considerations for clinicians and industry professionals.
Learn about the barriers to Implementing PGx Testing
End of content
End of content
Join Our Insider’s Circle! Stay up to Date with the latest in PGx